STOCK TITAN

Motus Gi Hldgs Inc Stock Price, News & Analysis

MOTS OTC

Welcome to our dedicated page for Motus Gi Hldgs news (Ticker: MOTS), a resource for investors and traders seeking the latest updates and insights on Motus Gi Hldgs stock.

Motus GI Holdings, Inc. (NASDAQ: MOTS) delivers innovative solutions for gastrointestinal diagnostics through its FDA-cleared Pure-Vu® system. This dedicated news hub provides investors and healthcare professionals with essential updates on financial performance, regulatory milestones, and clinical adoption progress.

Access timely press releases covering earnings reports, partnership announcements, and technological advancements in colonoscopy preparation. Our curated collection serves as a strategic resource for tracking the company's progress in improving endoscopic visualization and patient outcomes.

Discover updates on U.S. and international commercialization efforts, regulatory submissions, and peer-reviewed clinical data. The content maintains strict adherence to factual reporting standards, ensuring reliable information for investment research and clinical decision-making.

Bookmark this page for streamlined access to Motus GI's latest developments in medical technology. Monitor updates on the Pure-Vu® system's integration into clinical workflows and its growing role in colorectal cancer prevention strategies.

Rhea-AI Summary

Motus GI Holdings, a medical technology company, reported its Q1 2024 financial results and corporate updates. The U.S. launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system doubled the number of active customers, with 100% adopting the system independently. The company appointed an investment bank to explore strategic alternatives to boost commercialization and stockholder value. Revenues for Q1 2024 increased to $64,000 from $56,000 in Q1 2023, primarily from disposable sleeve reorders. Despite this, the net loss deepened to $7.6 million from $4.4 million year-over-year. Cash and equivalents stood at $4.9 million as of March 31, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.05%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.54%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.18%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
68.71%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-39.07%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.75%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.71%
Tags
none

FAQ

What is the current stock price of Motus Gi Hldgs (MOTS)?

The current stock price of Motus Gi Hldgs (MOTS) is $0.0003 as of June 20, 2025.

What is the market cap of Motus Gi Hldgs (MOTS)?

The market cap of Motus Gi Hldgs (MOTS) is approximately 435.1K.
Motus Gi Hldgs Inc

OTC:MOTS

MOTS Rankings

MOTS Stock Data

435.11k
6.33M
0.9%
5.25%
0.45%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
FT. LAUDERDALE